A Day Up For Reneo Pharmaceuticals Inc.

Wed, Oct 16, 2024 at 07:48 PM

Reneo Pharmaceuticals Inc. (RPHM:NASDAQ) rocketted at $18.2, representing a gain of 952%. On Wed, Oct 16, 2024, RPHM:NASDAQ hit a New 2-Week Intraday Low of $1.68. The stock appeared on our News Catalysts scanner on Mon, Oct 07, 2024 at 07:28 AM in the 'MERGER' category. From Wed, Oct 02, 2024, the stock recorded 20.00% Up Days and 90.91% Green Days

The share price of the company has been moving sideways in recent weeks.

About Reneo Pharmaceuticals Inc. (RPHM:NASDAQ)

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company.

Top 10 Gainers:

Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
Santech Holdings Ltd ADS (STEC:NASDAQ), 646.89%
180 Life Sciences Corp. (ATNF:NASDAQ), 325.66%
Versus Systems Inc. (VS:NASDAQ), 249.56%
VS Media Holdings Limited (VSME:NASDAQ), 128.87%
ProQR Therapeutics N.V. (PRQR:NASDAQ), 122.1%
Korro Bio, Inc. (KRRO:NASDAQ), 93.66%
Wave Life Sciences Ltd. (WVE:NASDAQ), 74.07%
Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 73.55%
Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 67.63%